Article | Takeda oncology vet joins bit.bio as COO
November 19, 2021 | Published by bit.bio
COO Kathryn Corzo
CAMBRIDGE, UK, Friday 19 November 2021 - The appointment of Kathryn Corzo as bit.bio's Chief Operating Officer was the feature story in the END Points weekly biopharma job report Peer Review. Corzo spoke with reporters about her career to date, what inspired her to go into biopharma and what prompted her to join bit.bio.
“And I saw that individual go through treatment, and really, really suffer through treatment. Now, the positive outcome is that he’s in remission. He has lived his life, and he is doing extremely well. But that, for me, galvanized my interest in working to develop new cancer therapies. ”